30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Lee Philina

Track

Insider profile

Performance

Overall performance
2.7
Performance over holding periods
2.7
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 95% 68% 82%
Transactions
7 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Lee Philina's trades of Blueprint Medicines Corp's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-07 2025-03-05
S Sale
58,543 -7.1%
43.81
US$1,674,088 		58,543 -7.1% 43.81 US$1,674,088
2024-08-07 2024-08-05
S Sale
82,412 -40.7%
411.88
US$1,428,350 		82,412 -40.7% 411.88 US$1,428,350
2024-08-05 2024-08-05
PrS Proposed sale
90,353
118.71
US$4,621,961 		90,353 118.71 US$4,621,961
2024-03-15 2024-03-13
S Sale
1,800 -4.9%
89.88
US$161,784 		1,800 -4.9% 89.88 US$161,784
2024-03-15 2024-03-13
S Sale
6,223 -14.6%
90.55
US$563,493 		6,223 -14.6% 90.55 US$563,493
2024-03-13 2024-03-13
PrS Proposed sale
8,023
89.00
US$714,047 		8,023 89.00 US$714,047
2024-03-11 2024-03-07
S Sale
2,934 -6.7%
90.69
US$266,084 		2,934 -6.7% 90.69 US$266,084
2023-03-08 2023-03-06
S Sale
54 -0.2%
44.40
US$2,398 		54 -0.2% 44.40 US$2,398
2023-03-08 2023-03-06
S Sale
1,622 -4.9%
45.72
US$74,158 		1,622 -4.9% 45.72 US$74,158